Product Information

ACETAMINOPHEN 325 MG TABLET is a generic product labeled by McKesson, priced at $0.0250 per EA under NDC 68599467909. Its NADAC has been published 201 times since Aug 24, 2022.

ACETAMINOPHEN 325 MG TABLET

Acetaminophen
$0.0250per EA
OTC

Strength

325 mg/1

Manufacturer

McKesson

NDC

68599467909

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

ACETAMINOPHEN

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M013

On Market Since

4/1/2021

Price Statistics

The NADAC for ACETAMINOPHEN 325 MG TABLET has been published 201 times since Aug 24, 2022, and over the history we have for it it has risen 13.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0250 per EA
All-time high$0.0267 (Nov 13, 2024)
All-time low$0.0219 (Aug 23, 2023)
52-week high$0.0267
52-week low$0.0247
Median price$0.0245
Average price$0.0245
Largest weekly change-17.3% (Nov 20, 2024)
Weeks tracked201
Tracking sinceAug 24, 2022

Price History

1W

0.0%

1M

-1.0%

3M

-4.8%

6M

-6.4%

1Y

+1.1%

3Y

+7.6%

5Y

N/A

All

+13.6%

Generic Alternatives

The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ACETAMINOPHEN 325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN 325 MG TABLET, manufactured by McKesson, is $0.0250 per EA (NDC 68599467909), effective Jun 24, 2026.

How has the price of ACETAMINOPHEN 325 MG TABLET changed over time?

Over the history we have for it, the NADAC for ACETAMINOPHEN 325 MG TABLET has risen 13.6%. It has been tracked across 201 weekly CMS publications since Aug 24, 2022.

What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN 325 MG TABLET?

Since Aug 24, 2022, the NADAC for ACETAMINOPHEN 325 MG TABLET has ranged from a low of $0.0219 (Aug 23, 2023) to a high of $0.0267 (Nov 13, 2024), with a median of $0.0245 per EA.

Are there cheaper alternatives to ACETAMINOPHEN 325 MG TABLET?

Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, QC PAIN RELIEF 325 MG TABLET, is $0.0232 per EA — about 7% below ACETAMINOPHEN 325 MG TABLET.

Who manufactures ACETAMINOPHEN 325 MG TABLET?

ACETAMINOPHEN 325 MG TABLET (NDC 68599467909) is labeled by McKesson, and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.